(1R01GM114080 Administrative Supplement) As a part of my current project (R01GM114081), we need to synthesize peptides, conjugate them with polymers, purify the conjugates, and characterize the nanoparticles. Currently, we are completing the studies proposed in the Aim 2 and proceeding to the experiments of Aim 3. However, for the studies to proceed at the desired pace, we need to synthesize the polymers, peptides, the conjugates, purify and characterize them. In addition, we also need a gel-permeation chromatography set-up to characterize the synthesized polymers and the polymer- peptide conjugates. We are using an HPLC system in our laboratory for purifying the synthesized peptides. We are using the HPLC system with a gel-permeation column for determining the molecular weights and the polydispersity indices of the polymers and their peptide conjugates. The instrument is more than ten years old. Due to the age, the instrument is subject to frequent maintenance issues and servicing. The HPLC problems are slowing us on the project, and I am actively looking into funding sources to replace the old HPLC instrument. A new HPLC instrument with fluorescence and refractive index detectors would cost $64,145 from Shimadzu (quotation included in the request). Since our current HPLC system is from Shimadzu, I contacted them for the quotation of a new instrument. We are familiar with the instrument, controls, software, and troubleshooting aspects of the Shimadzu HPLC system. The requested funds would allow us to purchase a new Shimadzu HPLC-GPC combined system for timely-conclusion of the funded project. The instrument would also aid in the competitive renewal of the NIH R01 award.

Public Health Relevance

The proposed research is relevant to public health in developing polymeric vesicles for targeting to tumors and subsequent release of the encapsulated drugs. The outcome of the proposed administrative supplement will fulfill a part of the NIGMS mission of undertaking fundamental research, which will be applicable in treating human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM114080-04S1
Application #
9707449
Study Section
Gene and Drug Delivery Systems Study Section (GDD)
Program Officer
Okita, Richard T
Project Start
2015-09-05
Project End
2019-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
North Dakota State University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
803882299
City
Fargo
State
ND
Country
United States
Zip Code
58108
Karandish, Fataneh; Froberg, James; Borowicz, Pawel et al. (2018) Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors. Colloids Surf B Biointerfaces 163:225-235
Pi, Fengmei; Binzel, Daniel W; Lee, Tae Jin et al. (2018) Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol 13:82-89
You, Seungyong; Froberg, James; Yu, Junru et al. (2017) Real-time monitoring of conformational transitions of single-molecule histone deacetylase 8 with nanocircuits. Chem Commun (Camb) 53:3307-3310
Kumar, Krishna N; Mallik, Sanku; Sarkar, Kausik (2017) Role of freeze-drying in the presence of mannitol on the echogenicity of echogenic liposomes. J Acoust Soc Am 142:3670
Fouladi, Farnaz; Steffen, Kristine J; Mallik, Sanku (2017) Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs. Bioconjug Chem 28:857-868
Anajafi, Tayebeh; Yu, Junru; Sedigh, Abbas et al. (2017) Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors. Mol Pharm 14:1916-1928
Lee, Tae Jin; Yoo, Ji Young; Shu, Dan et al. (2017) RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21. Mol Ther 25:1544-1555
Karandish, Fataneh; Haldar, Manas K; You, Seungyong et al. (2016) Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids. ACS Omega 1:952-962
Karandish, Fataneh; Mallik, Sanku (2016) Biomarkers and Targeted Therapy in Pancreatic Cancer. Biomark Cancer 8:27-35
Binzel, Daniel W; Shu, Yi; Li, Hui et al. (2016) Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. Mol Ther 24:1267-77

Showing the most recent 10 out of 18 publications